Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CNIH3 antisense RNA 1 (CNIH3-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand near the CNIH3 gene (cornichon family AMPA receptor auxiliary protein 3).[1][7] While the detailed function of CNIH3-AS1 remains to be elucidated in public annotations, it likely represents a regulatory RNA involved in modulating the expression or stability of its neighboring sense gene, CNIH3, through mechanisms typical of antisense lncRNAs such as mRNA stabilization, recruitment of chromatin modifiers, or acting as competing endogenous RNA (ceRNA)[3]. There is currently no direct evidence categorizing CNIH3-AS1 itself as a therapeutic target, receptor, enzyme, transporter, or similar druggable entity, nor are there validated drug interactions, mechanisms of action, or established biomarker or safety data for this lncRNA in available resources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CNIH3 antisense RNA 1 (CNIH3-AS1).